Insulin Market in Europe 2015-2019

Most up-to-date research on "Insulin Market in Europe 2015-2019" to its huge collection of research reports.

Insulin is a hormone produced by the beta cells of the pancreas; insulin has a key role in regulating the blood glucose levels. It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the food for energy or to store glucose for future use. The beta cells of the pancreas of people with type 1 diabetes do not produce sufficient insulin to regulate blood glucose level; therefore, they need to intake insulin daily. On the other hand, people with type 2 diabetes or gestational diabetes need doses of insulin together with other medication. Different type of insulin such as human insulin and insulin analogs are available for insulin replacement therapy.

Market analysts forecast the insulin market in Europe to grow at a CAGR of 6.50% over the period 2014-2019.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=sample&repid=354438

Covered in this report

The report covers the present scenario and the growth prospects of the insulin market in Europe for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of various insulin used for the treatment of diabetes.

New report, Insulin Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the insulin market in Europe and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

Elli Lilly

Novo Nordisk

Sanofi

Other prominent vendors

Biodel

Boehringer Ingelheim

Bristol-Myers Squibb

Diamyd Medical

DiaVacs

Generex Biotechnology

Lexicon Pharmaceuticals

Macrogenics

Merck

Osiris Therapeutics

Pfizer

Tolerion

XOMA

Key market driver

Increase in prevalence of...